Eric Edidin

Blackstone Corporate Private Equity (Blackstone Corporate) is a private equity division of The Blackstone Group Inc founded in 1985 by Stephen Allen Schwarzman. The firm is headquartered in New York.

Spartacus Acquisition Corp. operates as a blank check company. It is formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, and reorganization. The company was founded on August 10, 2020 and is headquartered ion Duluth, GA.

ILiAD Biotechnologies LLC operates as a clinical stage biotechnology company, focuses on the prevention and treatment of disease caused by Bordetella Pertussis. It offers BPZE1, a live-attenuated pertussis vaccine that has completed Phase 1 human clinical trial. The company was founded by Keith Rubin in 2012 and is headquartered in New York, NY.

Cecelia Health, Inc. provides web based diabetes coaching services. The firm offers Fit4D platform that provides electronic interactions in patient-preferred modalities, such as phone, email, text, web that address patient specific issues in the patient’s preferred format, including articles, videos, and webinars. The company was founded by David G. Weingard in 2009 and is headquartered in New York, NY.

The Jewish Federation Council of Los Angeles provides emergency relief and social services. It identifies and funds social service, humanitarian needs in Israel and around the world. It helps to alleviate Jewish poverty, provide emergency relief, and support the Los Angeles community. The organization is headquartered in Los Angeles, CA

Begin a Legacy, Inc. develops software application that allows individuals and companies to start and run a nonprofit. It also provides education on nonprofit best practices and distributes grants to organizations. The company was founded by Dominic Kalms in 2016 and is headquartered in Los Angeles, CA.

Diasome Pharmaceuticals, Inc. operates as a clinical stage diabetes therapeutics company which designs and develops insulin-based therapies for the treatment of diabetes. It focuses on the clinical and commercial development of breakthrough therapies for diabetes and obesity. The company’s technology platform is based on the use of its proprietary Hepatocyte Directed Vesicle or HDV, nanotechnology to deliver a wide range of critically necessary hormones and drugs to the liver, the body’s primary site of glucose storage. The firm’s HDV system is designed to fundamentally improve the way in which insulin works in people with diabetes by enabling much greater amounts of injected insulin to reach hepatocytes, the liver’s glucose storing cells. The company was founded by Len Rosenberg, Lance Converse, W. Blair Geho and Robert Geho in 2004 and is headquartered in Cleveland, OH.